Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced its Board of Directors has authorized ...
EMERYVILLE, Calif. (AP) — EMERYVILLE, Calif. (AP) — Dynavax Technologies Corp. (DVAX) on Thursday reported third-quarter net income of $17.6 million. On a per-share basis, the Emeryville, ...
Whether you're looking for adventure, work opportunities, new scenery or better weather conditions, California cities represent a special, sunny place in the popular imagination. But before packing ...
XOMA Royalty recorded total income and revenues of $7.2 million for the third quarter of 2024, which included $6.5 million in estimated income associated with two commercial products in our portfolio.